<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Rexahn Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Rexahn Pharmaceuticals, Inc.

    Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to developing innovative therapeutics for the treatment of cancer. Rexahn currently has two clinical stage oncology candidates, RX-3117 and RX-5902 (Supinoxin™), and additional compounds in preclinical development to treat multiple types of cancer. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Douglas J. Swirsky
    • FOUNDED
      2001
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Inovalon Holdings, Inc.

    Inovalon Holdings, Inc.

    Inovalon is a leading technology company providing cloud-based platforms empowerin...

    Inovalon is a leading technology company provid...

    Filing Type:    PU
    Seres Therapeutics, Inc.

    Seres Therapeutics, Inc.

    Seres Therapeutics, Inc. is a microbiome therapeutics platform company developing ...

    Seres Therapeutics, Inc. is a microbiome therap...

    Filing Type:    PU
    Aldeyra Therapeutics, Inc.

    Aldeyra Therapeutics, Inc.

    Aldeyra Therapeutics is a biotechnology company devoted to developing and commerci...

    Aldeyra Therapeutics is a biotechnology company...

    Filing Type:    PU
    TherapeuticsMD, Inc.

    TherapeuticsMD, Inc.

    TherapeuticsMD, Inc. is an innovative pharmaceutical company exclusively committed...

    TherapeuticsMD, Inc. is an innovative pharmaceu...

    Filing Type:    PU
    Dova Pharmaceuticals, Inc.

    Dova Pharmaceuticals, Inc.

    Dova is a pharmaceutical company focused on acquiring, developing and commercializ...

    Dova is a pharmaceutical company focused on acq...

    Filing Type:    PU
    Cassava Sciences, Inc.

    Cassava Sciences, Inc.

    The mission of Cassava Sciences is to detect and treat neurodegenerative diseases,...

    The mission of Cassava Sciences is to detect an...

    Filing Type:    PU
    Allogene Therapeutics, Inc.

    Allogene Therapeutics, Inc.

    Allogene Therapeutics is a clinical stage biotechnology company pioneering the dev...

    Allogene Therapeutics is a clinical stage biote...

    Filing Type:    PU
    Immunomedics, Inc.

    Immunomedics, Inc.

    Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal a...

    Immunomedics is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    NeoGenomics, Inc.

    NeoGenomics, Inc.

    NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory and phar...

    NeoGenomics, Inc. is a high-complexity CLIA-cer...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.